MARC details
000 -LEADER |
fixed length control field |
04323naaaa2201333uu 4500 |
001 - CONTROL NUMBER |
control field |
https://directory.doabooks.org/handle/20.500.12854/51985 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20220714163344.0 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
books978-3-03842-950-0 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783038429500 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783038429494 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.3390/books978-3-03842-950-0 |
Terms of availability |
doi |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
English |
042 ## - AUTHENTICATION CODE |
Authentication code |
dc |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Fareed, Jawed |
Relator code |
auth |
9 (RLIN) |
535661 |
245 10 - TITLE STATEMENT |
Title |
Looking Forward to the Future of Heparin: New Sources, Developments and Applications |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Name of publisher, distributor, etc |
MDPI - Multidisciplinary Digital Publishing Institute |
Date of publication, distribution, etc |
2018 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 electronic resource (282 p.) |
506 0# - RESTRICTIONS ON ACCESS NOTE |
Terms governing access |
Open Access |
Source of term |
star |
Standardized terminology for access restriction |
Unrestricted online access |
520 ## - SUMMARY, ETC. |
Summary, etc |
This book is a printed edition of the Special Issue Looking Forward to the Future of Heparin: New Sources, Developments and Applications that was published in Molecules |
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
Terms governing use and reproduction |
Creative Commons |
-- |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
-- |
cc |
-- |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
546 ## - LANGUAGE NOTE |
Language note |
English |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
alginate |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
n/a |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
edema |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Heparin Red |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
solid lipid nanoparticles |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Fe3O4·DA-BSA/HA |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
dermatan sulfate |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
sulfated alginate |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
porcine heparin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
theranostics |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
low-molecular-weight heparin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Arixtra® |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
biomaterials |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hepcidin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
ovarian cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
iron oxide nanoparticles |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
heparin-induced thrombocytopenia |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
bone morphogenetic protein (BMP) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hyaluronic acid (HA) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
crude heparin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
platelets |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
resistance |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
sclerostin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
LMWH |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
gremlin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
low molecular weight heparin (LMWH) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
low molecular weight glycosaminoglycans |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
human plasma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
single crystal X-ray structure |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
iron homeostasis |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
noggin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
super paramagnetic iron oxide nanoparticles (SPION) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
manufacturing methods |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
paclitaxel (PTX) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
brain injury |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
bovine heparin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
inflammation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
qNMR |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
antithrombin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
reference standard |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
quantitative NMR |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
enoxaparin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
danaparoid sodium |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
NMR |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
GDNF |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
orthogonal multi-analytical methods |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
ternary complex |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
heparan sulphate |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
serglycin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
bovine serum albumin (BSA) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
HSQC |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
recombinant expression |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
heparin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
heparin oligosaccharides |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
functional assay |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
BMP antagonists |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
intestinal lymphatic absorption |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
size exclusion chromatography |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
heparin coating |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
diagnosis |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
bioreactor |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
anemia |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
proteoglycan |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
heparin process |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
PCA |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
chemometric |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
fluorescent probe |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
pharmacopeia |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
affinity chromatography |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
component quantitative analysis |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Fondaparinux sodium |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
perylene diimide dyes |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
thrombin inhibition |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
extended physicochemical characterization |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cisplatin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
glycosaminoglycans |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
TGF-? |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
chondroitin sulfate |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
dalteparin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
sequence and compositional investigations |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
molecular weight |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
magnetic resonance imaging (MRI) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
industrial |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
LC-MS |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
iduronic acid conformation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
heparan sulfate |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
growth and differentiation factor (GDF) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
assay |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
subarachnoid hemorrhage |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Torri, Giangiacomo |
Relator code |
auth |
9 (RLIN) |
1576183 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://mdpi.com/books/pdfview/book/677">https://mdpi.com/books/pdfview/book/677</a> |
-- |
0 |
Public note |
DOAB: download the publication |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://directory.doabooks.org/handle/20.500.12854/51985">https://directory.doabooks.org/handle/20.500.12854/51985</a> |
-- |
0 |
Public note |
DOAB: description of the publication |